Improved Segmentation of the Intracranial and Ventricular Volumes in Populations with Cerebrovascular Lesions and Atrophy Using 3D CNNs.

Journal: Neuroinformatics
Published Date:

Abstract

Successful segmentation of the total intracranial vault (ICV) and ventricles is of critical importance when studying neurodegeneration through neuroimaging. We present iCVMapper and VentMapper, robust algorithms that use a convolutional neural network (CNN) to segment the ICV and ventricles from both single and multi-contrast MRI data. Our models were trained on a large dataset from two multi-site studies (N = 528 subjects for ICV, N = 501 for ventricular segmentation) consisting of older adults with varying degrees of cerebrovascular lesions and atrophy, which pose significant challenges for most segmentation approaches. The models were tested on 238 participants, including subjects with vascular cognitive impairment and high white matter hyperintensity burden. Two of the three test sets came from studies not used in the training dataset. We assessed our algorithms relative to four state-of-the-art ICV extraction methods (MONSTR, BET, Deep Extraction, FreeSurfer, DeepMedic), as well as two ventricular segmentation tools (FreeSurfer, DeepMedic). Our multi-contrast models outperformed other methods across many of the evaluation metrics, with average Dice coefficients of 0.98 and 0.96 for ICV and ventricular segmentation respectively. Both models were also the most time efficient, segmenting the structures in orders of magnitude faster than some of the other available methods. Our networks showed an increased accuracy with the use of a conditional random field (CRF) as a post-processing step. We further validated both segmentation models, highlighting their robustness to images with lower resolution and signal-to-noise ratio, compared to tested techniques. The pipeline and models are available at: https://icvmapp3r.readthedocs.io and https://ventmapp3r.readthedocs.io to enable further investigation of the roles of ICV and ventricles in relation to normal aging and neurodegeneration in large multi-site studies.

Authors

  • Emmanuel E Ntiri
    Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, Canada.
  • Melissa F Holmes
    Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, Canada.
  • Parisa M Forooshani
    Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, Canada.
  • Joel Ramirez
    LC Campbell Cognitive Neurology Unit, Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
  • Fuqiang Gao
    LC Campbell Cognitive Neurology Unit, Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
  • Miracle Ozzoude
    LC Campbell Cognitive Neurology Unit, Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
  • Sabrina Adamo
    LC Campbell Cognitive Neurology Unit, Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
  • Christopher J M Scott
    Sunnybrook Research Institute, Toronto, Ontario.
  • Dar Dowlatshahi
    Department of Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada.
  • Jane M Lawrence-Dewar
    Thunder Bay Regional Health Research Institute, Thunder Bay, Canada.
  • Donna Kwan
    Department of Psychology, Faculty of Health, York University, Toronto, Canada.
  • Anthony E Lang
    The Edmond J. Safra Program in Parkinson's Disease and Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, Toronto, Canada.
  • Sean Symons
    Department of Medical Imaging, University of Toronto, Toronto, Canada.
  • Robert Bartha
    Department of Medical Biophysics, Schulich School of Medicine and Dentistry, Robarts Research Institute, University of Western Ontario, London, Canada.
  • Stephen Strother
    Department of Medical Biophysics, University of Toronto, Toronto, Canada.
  • Jean-Claude Tardif
    Montreal Heart Institute, Université de Montréal, Montreal, QC.
  • Mario Masellis
    Canadian Partnership for Stroke Recovery, Heart and Stroke Foundation, Toronto, Ontario, Canada.
  • Richard H Swartz
    Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, Canada.
  • Alan Moody
    Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, Canada.
  • Sandra E Black
    Institute of Medical Science, University of Toronto, Toronto, ON Canada.
  • Maged Goubran
    Imaging Research Laboratories, Robarts Research Institute, London, ON, Canada N6A 5K8; Biomedical Engineering Graduate Program, Western University, London, ON, Canada. Electronic address: mgoubran@robarts.ca.